132 related articles for article (PubMed ID: 30796948)
21. Contraceptive use of antiprogestin.
Bygdeman M; Danielsson KG; Marions L; Swahn ML
Eur J Contracept Reprod Health Care; 1999 Jun; 4(2):103-7. PubMed ID: 10427485
[TBL] [Abstract][Full Text] [Related]
22. The use of progesterone antagonists and progesterone receptor modulators in contraception.
Spitz IM; Van Look PF; Coelingh Bennink HJ
Steroids; 2000; 65(10-11):817-23. PubMed ID: 11108893
[TBL] [Abstract][Full Text] [Related]
23. Leukaemia inhibitory factor receptor and gp130 in the human Fallopian tube and endometrium before and after mifepristone treatment and in the human preimplantation embryo.
Wånggren K; Lalitkumar PG; Hambiliki F; Ståbi B; Gemzell-Danielsson K; Stavreus-Evers A
Mol Hum Reprod; 2007 Jun; 13(6):391-7. PubMed ID: 17430984
[TBL] [Abstract][Full Text] [Related]
24. Effect of low weekly doses of mifepristone on ovarian function and endometrial development.
Gemzell-Danielsson K; Westlund P; Johannisson E; Swahn ML; Bygdeman M; Seppälä M
Hum Reprod; 1996 Feb; 11(2):256-64. PubMed ID: 8671205
[TBL] [Abstract][Full Text] [Related]
25. Fertility impairment after mifepristone treatment to rats at proestrus. Actions on the hypothalamic-hypophyseal-ovarian axis.
Telleria CM; Mezzadri MR; Deis RP
Contraception; 1997 Oct; 56(4):267-74. PubMed ID: 9408709
[TBL] [Abstract][Full Text] [Related]
26. Ulipristal acetate administration at mid-cycle changes gene expression profiling of endometrial biopsies taken during the receptive period of the human menstrual cycle.
Lira-Albarrán S; Durand M; Larrea-Schiavon MF; González L; Barrera D; Vega C; Gamboa-Domínguez A; Rangel C; Larrea F
Mol Cell Endocrinol; 2017 May; 447():1-11. PubMed ID: 28219738
[TBL] [Abstract][Full Text] [Related]
27. Effect of follicular phase administration of mifepristone (RU486) on blastocyst implantation in the rhesus monkey.
Ghosh D; Nayak NR; Sengupta J
Contraception; 1997 Aug; 56(2):117-22. PubMed ID: 9315421
[TBL] [Abstract][Full Text] [Related]
28. Effects of ulipristal acetate on human embryo attachment and endometrial cell gene expression in an in vitro co-culture system.
Berger C; Boggavarapu NR; Menezes J; Lalitkumar PG; Gemzell-Danielsson K
Hum Reprod; 2015 Apr; 30(4):800-11. PubMed ID: 25740886
[TBL] [Abstract][Full Text] [Related]
29. Failure of oestrogen induced luteinizing hormone surge in women treated with mifepristone (RU 486) every day for 30 days.
Baird DT; Thong KJ; Hall C; Cameron ST
Hum Reprod; 1995 Sep; 10(9):2270-6. PubMed ID: 8530650
[TBL] [Abstract][Full Text] [Related]
30. Effect of early luteal phase administration of mifepristone (RU486) on leukaemia inhibitory factor, transforming growth factor beta and vascular endothelial growth factor in the implantation stage endometrium of the rhesus monkey.
Ghosh D; Kumar PG; Sengupta J
J Endocrinol; 1998 Apr; 157(1):115-25. PubMed ID: 9614365
[TBL] [Abstract][Full Text] [Related]
31. Effects of long-term low-dose mifepristone on reproductive function in women.
Croxatto HB; Kovács L; Massai R; Resch BA; Fuentealba B; Salvatierra AM; Croxatto HD; Zalányi S; Viski S; Krenács L
Hum Reprod; 1998 Apr; 13(4):793-8. PubMed ID: 9619526
[TBL] [Abstract][Full Text] [Related]
32. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE; Kettel LM; Yen SS
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[TBL] [Abstract][Full Text] [Related]
33. The possible use of antiprogestins for contraception.
Bygdeman M; Danielsson KG; Swahn ML
Acta Obstet Gynecol Scand Suppl; 1997; 164():75-7. PubMed ID: 9225644
[TBL] [Abstract][Full Text] [Related]
34. Antinidatory effect of luteal phase administration of mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window.
Nayak NR; Sengupta J; Ghosh D
Contraception; 1998 Aug; 58(2):111-7. PubMed ID: 9773266
[TBL] [Abstract][Full Text] [Related]
35. Immunolocalization of Le(y) oligosaccharide in endometrium during menstrual cycle and effect of early luteal phase mifepristone administration on its expression in implantation stage endometrium of the rhesus monkey.
Ghosh D; Liu N; Zhu ZM; Sengupta J
Hum Reprod; 1998 May; 13(5):1374-9. PubMed ID: 9647575
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone.
Kannan A; Bhurke A; Sitruk-Ware R; Lalitkumar PG; Gemzell-Danielsson K; Williams ARW; Taylor RN; Bagchi MK; Bagchi IC
Reprod Sci; 2018 Mar; 25(3):320-328. PubMed ID: 29241443
[TBL] [Abstract][Full Text] [Related]
37. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
Swahn ML; Bygdeman M; Cekan S; Xing S; Masironi B; Johannisson E
Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
[TBL] [Abstract][Full Text] [Related]
38. Effect of ulipristal acetate and mifepristone at emergency contraception dose on the embryo-endometrial attachment using an in vitro human trophoblastic spheroid and endometrial cell co-culture model.
Li HWR; Li YX; Li TT; Fan H; Ng EH; Yeung WS; Ho PC; Lee KF
Hum Reprod; 2017 Dec; 32(12):2414-2422. PubMed ID: 29121217
[TBL] [Abstract][Full Text] [Related]
39. Regulation of bcl-2 gene family members in human endometrium by antiprogestin administration in vivo.
Critchley HO; Tong S; Cameron ST; Drudy TA; Kelly RW; Baird DT
J Reprod Fertil; 1999 Mar; 115(2):389-95. PubMed ID: 10434946
[TBL] [Abstract][Full Text] [Related]
40. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ
Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
